CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED

Company number 09686738

Date	Type	Description	View / Download
11 Feb 2021	PSC09	Withdrawal of a person with significant control statement on 11 February 2021	(2 pages)
10 Feb 2021	TM01	Termination of appointment of Robert Giles Tansley as a director on 29 January 2021	(1 page)
10 Feb 2021	TM01	Termination of appointment of Nicholas Morrell as a director on 29 January 2021	(1 page)
10 Feb 2021	AP01	Appointment of Ms Marella Thorell as a director on 29 January 2021	(2 pages)
10 Feb 2021	TM01	Termination of appointment of Kevin Stuart Johnson as a director on 29 January 2021	(1 page)
10 Feb 2021	TM01	Termination of appointment of David John Grainger as a director on 29 January 2021	(1 page)
10 Feb 2021	AP01	Appointment of Mr Iqbal Hussain as a director on 29 January 2021	(2 pages)
10 Feb 2021	AP01	Appointment of Dr Saurabh Saha as a director on 29 January 2021	(2 pages)
10 Feb 2021	TM01	Termination of appointment of Anne Michelle Dobrée as a director on 29 January 2021	(1 page)
14 Jan 2021	RESOLUTIONS	Resolutions RES09 ‐ Resolution of authority to purchase a number of shares	(2 pages)
14 Jan 2021	SH06	Cancellation of shares. Statement of capital on 30 December 2020 GBP 35,469.22	(8 pages)
02 Oct 2020	AD01	Registered office address changed from C/O the Cambridge Partnership Limited the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3AT United Kingdom to C/O the Cambridge Partnership Ltd, the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3FH on 2 October 2020	(1 page)
27 Aug 2020	AD01	Registered office address changed from Moneta Building Babraham Research Campus Cambridge CB22 3AT England to C/O the Cambridge Partnership Limited the Dorothy Hodgkin Building Babraham Research Campus, Babraham Cambridge CB22 3AT on 27 August 2020	(1 page)
15 Jul 2020	CS01	Confirmation statement made on 14 July 2020 with no updates	(3 pages)
21 Apr 2020	AA	Accounts for a small company made up to 31 July 2019	(7 pages) Download iXBRL
15 Jul 2019	CS01	Confirmation statement made on 14 July 2019 with updates	(7 pages)
26 Apr 2019	AA	Total exemption full accounts made up to 31 July 2018	(7 pages) Download iXBRL
25 Apr 2019	SH01	Statement of capital following an allotment of shares on 15 April 2019 GBP 35,626	(4 pages)
15 Jan 2019	SH01	Statement of capital following an allotment of shares on 15 January 2019 GBP 35,087.35	(4 pages)
08 Jan 2019	RESOLUTIONS	Resolutions RES01 ‐ Resolution of adoption of Articles of Association	(69 pages)
18 Dec 2018	SH01	Statement of capital following an allotment of shares on 14 December 2018 GBP 33,507.29	(4 pages)
20 Sep 2018	RP04SH01	Second filing of a statement of capital following an allotment of shares on 8 August 2018 GBP 22,388.06	(9 pages)
21 Aug 2018	SH01	Statement of capital following an allotment of shares on 8 August 2018 GBP 22,388.06 ANNOTATION Clarification a second filed SH01 was registered on 20/09/2018	(5 pages)
24 Jul 2018	CS01	Confirmation statement made on 14 July 2018 with no updates	(3 pages)
23 Apr 2018	AA	Total exemption full accounts made up to 31 July 2017	(7 pages) Download iXBRL

Previous

• 1
• 2
• 3
• 4

Next